Background In November 2017, the Food and Drug Administration (FDA) approved a version of a second-generation antipsychotic, aripiprazole, embedded with a sensor (Abilify MyCite). Objective To ...

We report two cases in which aripiprazole, an atypical antipsychotic, was effective in treating such symptoms. In both cases, traditional approaches such as antidepressants and supportive therapy were ...

American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, May 27-30, Scottsdale Psych Congress Elevate, May 28-31, Las Vegas "Alkermes is honored to present at these notable ...